Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Grapefruit Benefits

IGF Oncology Announces Targeted Cancer Drug Results
IGF Oncology, a St. Paul-based company, reported the publication of results of a study of its new targeted anti-cancer drug in a peer-reviewed scientific journal. The company"s drug is a modified version of a commonly used cancer chemotherapy drug, modified to be targeted much more specifically to cancer cells and to bypass healthy cells. The results in mice, which are reported in the June issue of Translational Research, show the drug is significantly more effective than the standard drug, methotrexate, even at 6-fold lower dose. The lower dose is expected to result in lower side effects. The study was carried out in collaboration with the University of Minnesota. The authors include Hugh McTavish, the founder of IGF Oncology, and Arkadiusz Dudek, Oncologist and Assoc. Professor of Medicine at the University of Minnesota.
generic viagra online
UK Charity Tackles Health Risk For Children - Engaging Website Launches To Educate Children At A Crucial Age In Bone Development
Research from the National Osteoporosis Society has revealed that almost half (49%)* of young people do not know that there are steps they can take to keep their bones healthy. This knowledge gap puts them at risk of osteoporosis and fractures in later life.
News of the day
Sodexo's Training Strategy And Vocational Rehabilitation Program Recognized
Sodexo (PARIS:SW) (OTCBB:SDXAY) received two awards at the inaugural Professional Training Evening held May 25 in Paris: the "Best Training Strategy" award and the Favorites Award for "Successful vocational rehabilitation." The culmination of a 75-company competition, the event was organized jointly by France"s National Association of Human Res Directors (ANDRH), Professional Training Federation (FFP) and Association of Trainers and Training Managers (GARF).
Oncology

NewYork-Presbyterian/Columbia Physician-Scientists Present At 2009 American Transplant Congress In Boston

NewYork-Presbyterian Hospital/Columbia University Medical Center physician-scientists presented new research at the 2009 American Transplant Congress in Boston, May 30 to June 3. Topics included minimizing steroid exposure for liver transplant patients with hepatitis C; hypothermic machine perfusion vs. cold storage for preserving donor livers; and the effectiveness of neutrophil-lymphocyte ratio in predicting colorectal liver metastases in liver cancer patients undergoing transplantation. Dr. Jean Emond, chief of transplantation at NewYork-Presbyterian Hospital/Columbia University Medical Center and the Thomas S. Zimmer Professor of Surgery at Columbia University College of Physicians and Surgeons; and Dr. Dr. Robert S. Brown Jr., director of the Center for Liver Disease and Transplantation at NewYork-Presbyterian Hospital, chief of the Division of Abdominal Organ Transplantation and the Frank Cardile Professor of Medicine and Pediatrics in Surgery at Columbia University College of Physicians and Surgeons, are both available for comment on the following studies and on other news from the conference. Preservation/Reperfusion Injury Is Attenuated by Hypothermic Machine Perfusion in Human Liver Transplantation. Authors: Scot D. Henry, Ben Arrington, Benjamin Samstein, Sean W. C. Chen, Michael J. Goldstein, Jean C. Emond, H. Thomas Lee, James V. Guarrera In hypothermic machine perfusion (HMP), a solution is pumped through the donor organ at temperatures between 1°C and 10°C in order to preserve the organ for transplantation. The technique is only just beginning to be used in liver transplantation. In a study comparing donor livers preserved using cold storage without perfusion to donor livers preserved with HMP, the latter were shown to be better preserved, with significantly improved functional and molecular markers. Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome Following Liver Transplantation for Hepatocellular Carcinoma (HCC). Authors: Karim J. Halazun, Mark A. Hardy, Abbas A. Rana, David C. Woodland, Robert S. Brown, Jean C. Emond, Department of Organ Transplantation A retrospective analysis looked at neutrophil-lymphocyte ratio (NLR) -- an indicator of inflammatory status previously established as a prognostic tool in colorectal liver metastases -- and found it to be an effective tool for predicting risk for tumor recurrence and death in liver cancer patients receiving transplantation. Low-Dose Slowly-Tapered Steroids for Immunosuppression in Hepatitis C Virus Infected Liver Transplant Recipients: A 2-Year Follow-Up. Authors: E. Verna, E. Pichardo, J. Emond, R. Brown Jr. A two-year study of hepatitis C-infected patients receiving a liver transplant concluded that reducing the dosage and slowing the taper of the steroid regimen did not affect outcomes. Reducing steroid exposure may lessen the side effects of high-dose steroids, including increased risk of cardiovascular disease, high cholesterol and blood pressure, weight gain, diabetes, bone weakness and cataracts. The Effect of Socioeconomic Status on Survival and Fibrosis in Hepatitis C Virus Infected Liver Transplant Recipients: Experience at an Urban Referral Center. Authors: Verna, E. Pichardo, E. Farrand, J. Emond, R. Brown Jr. A retrospective study looked at the impact of socioeconomic status on the outcome of hepatitis C-infected patients receiving a liver transplant. They found that higher income is associated with improved one-year survival, but there was no association found between higher income and hepatitis C recurrence at one year. Incisional Hernias and Liver Transplantation: Assessment of Clinical Practice and Outcomes. Authors: B. Samstein, E. Pichardo, T. Perez, R. Brown Jr., J. Emond Incisional hernias (IH) -- protrusion of an organ through the wall that normally contains it -- are a well-known complication following liver transplantation (LT). An analysis of patients receiving hernia repair found it to be safe and effective. Columbia University Medical Center Columbia University Medical Center provides international leadership in basic, pre-clinical and clinical research, in medical and health sciences education, and in patient care. The Medical Center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians & Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Established in 1767, Columbia"s College of Physicians and Surgeons was the first institution in the country to grant the M.D. degree and is now among the most selective medical schools in the country. Columbia University Medical Center is home to the largest medical research enterprise in New York City and state and one of the largest in the United States. NewYork-Presbyterian Hospital


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009